Management of depressive symptoms in schizophrenia: a pooled, post hoc analysis from the asenapine development program

被引：0
|
作者：
Castle, D. [1 ]
Jensen, J. K. S. [2 ]
机构：
[1] Univ Western Australia, Melbourne, Vic, Australia
[2] H Lundbeck & Co AS, Dept Biostat, Valby, Denmark
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2013年 / 23卷
关键词：
D O I：
10.1016/S0924-977X(13)70797-1
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.3.f.019
引用
收藏
页码：S502 / S503
页数：2
相关论文
共 50 条
  • [41] Akathisia during cariprazine treatment: Post-hoc analyses of pooled schizophrenia studies
    Barabassy, A.
    Sebe, B.
    Szatmari, B.
    Laszlovszky, I.
    Harsanyi, J.
    Acsai, K.
    Seregi, B.
    Earley, W.
    Patel, M.
    Nemeth, G.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S323 - S323
  • [42] Effects of Asenapine in Bipolar I Patients Meeting Proxy Criteria for Moderate-to-Severe Mixed Major Depressive Episodes: A Post Hoc Analysis
    Berk, Michael
    Tiller, John W. G.
    Zhao, Jun
    Yatham, Lakshmi N.
    Malhi, Gin S.
    Weiller, Emmanuelle
    JOURNAL OF CLINICAL PSYCHIATRY, 2015, 76 (06) : 728 - +
  • [43] Dehydroepiandrosterone augmentation in the management of negative, depressive, and anxiety symptoms in schizophrenia
    Strous, RD
    Maayan, R
    Lapidus, R
    Stryjer, R
    Lustig, M
    Kotler, M
    Weizman, A
    ARCHIVES OF GENERAL PSYCHIATRY, 2003, 60 (02) : 133 - 141
  • [44] Lurasidone for the treatment of depressive symptoms in schizophrenia: analysis of 4 pooled, 6-week, placebo-controlled studies
    Nasrallah, Henry A.
    Cucchiaro, Josephine B.
    Mao, Yongcai
    Pikalov, Andrei A.
    Loebel, Antony D.
    CNS SPECTRUMS, 2015, 20 (02) : 140 - 147
  • [45] Lurasidone in the treatment of early-stage schizophrenia: a post-hoc analysis of three pooled acute treatment studies
    Lieberman, J.
    Pikalov, A.
    Hsu, J.
    Cucchiaro, J.
    Werner, P.
    Grossman, F.
    Loebel, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 : S488 - S489
  • [46] Lurasidone in the Treatment of Early-stage Schizophrenia: A Post-hoc Analysis of Three Pooled Acute Treatment Studies
    Lieberman, Jeffrey
    Pikalov, Andrei
    Hsu, Jay
    Cucchiaro, Josephine
    Grossman, Fred
    Loebel, Antony
    NEUROPSYCHOPHARMACOLOGY, 2013, 38 : S528 - S529
  • [47] Cariprazine's efficacy in treating depressive symptoms - pooled data from schizophrenia, bipolar depression and major depression trials
    McIntyre, R. S.
    Csehi, R.
    Nemeth, G.
    EUROPEAN PSYCHIATRY, 2023, 66 : S297 - S298
  • [48] Cariprazine's efficacy in treating depressive symptoms - pooled data from schizophrenia, bipolar depression and major depression trials
    McIntyre, R. S.
    Csehi, R.
    Nemeth, G.
    EUROPEAN PSYCHIATRY, 2023, 66 : S297 - S298
  • [49] Safety and tolerability of switching to asenapine from other antipsychotic agents: pooled results from two randomized multicenter trials in stable patients with persistent negative symptoms in schizophrenia
    Cazorla, Pilar
    Mackle, Mary
    Zhao, Jun
    Ha, Xianwei
    Szegedi, Armin
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2012, 8 : 247 - 257
  • [50] Safety and tolerability of atogepant: A post hoc analysis of pooled data from four clinical trials
    Rizzoli, P.
    Marmura, M. J.
    Robblee, J.
    McVige, J. W.
    Sacco, S. E.
    Ferreira, R.
    Rekeda, L.
    Ma, J.
    Dabruzzo, B. L.
    Ashina, M.
    HEADACHE, 2022, 62 : 121 - 122
12345